Enlivex Therapeutics Ltd. (ENLV) Stock
ENLV Key Statistics
About Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.
CEO: Oren Hershkovitz. Company website
ENLV — Frequently Asked Questions
What is the ENLV stock price today?
Enlivex Therapeutics Ltd. (ENLV) trades at $2.24, down 47.42% on the day, as of Sep 20, 2026 15:01 UTC.
What is Enlivex Therapeutics Ltd.'s market cap?
Enlivex Therapeutics Ltd. has a market capitalisation of $54.44M, calculated from the live ENLV share price and shares outstanding.
What is the P/E ratio of ENLV?
ENLV trades at a trailing P/E of 0.09, from earnings per share of $25.46 over the last twelve months.
How much revenue does Enlivex Therapeutics Ltd. make?
Enlivex Therapeutics Ltd. generated revenue of $0.00 over the trailing twelve months.
What is the 52-week range for ENLV?
ENLV has traded between $0.75 and $10.61 over the past 52 weeks, and the last price is 78.9% below that high.
Is Enlivex Therapeutics Ltd. profitable?
Yes. Enlivex Therapeutics Ltd. keeps 0.00% of revenue as net income over the trailing twelve months.
What is the analyst price target for ENLV?
Wall Street analysts rate ENLV Buy, with an average price target of $15.00, 569.6% above the current price.
What sector is Enlivex Therapeutics Ltd. in?
Enlivex Therapeutics Ltd. is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in IL .
Who is the CEO of Enlivex Therapeutics Ltd.?
Oren Hershkovitz is the chief executive of Enlivex Therapeutics Ltd., which employs 71 people.
Where can I track ENLV in real time?
QFI Terminal shows ENLV with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See ENLV live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open ENLV in Terminal See plans